Sanofi Consumer Healthcare India Ltd

Wed 22/07/2026,15:29:55 | NSE : SANOFICONR

₹4610.0033.20 (0.73%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 4609.80

Previous Close

₹ 4576.80

Volume

5020

Mkt Cap ( Rs. Cr)

₹10617.12

High

₹ 4635.40

Low

₹ 4515.00

52 Week High

₹ 5512.00

52 Week Low

₹ 3975.00

Book Value Per Share

₹ 166.75

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Sanofi Consumer Healthcare India Ltd

Your Vote -

Buy

81.82%

Hold

0.00%

Sell

18.18%

81.82%

11 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

58%

Sell Order Quantity

42%

Bid Price

Qty

4556.10

1

4554.00

1

4554.00

1

4554.00

3

4553.00

2

Bid Total

3571

Bid Price

Qty

4563.80

1

4565.00

2

4565.00

2

4566.00

1

4566.00

1

Bid Total

2630

Option Chain

Analyzes market sentiment, predicts Sanofi Consumer Healthcare India Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sanofi Consumer - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial

    22 Jul 2026, 5:06PM Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia,

  • Sanofi Consumer has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 5:50PM As of June 2026, 71.27% is owned by Foreign Promoters and 28.73% by Public. <p align=justify> Institutional holds 20.45% (Insurance Companies 4.84%) a

  • Sanofi Consumer - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 3:43PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Sanofi Consumer - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2026, 3:42PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 3oth June 2026 is enclosed.

  • Sanofi Consumer - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    29 Jun 2026, 9:39PM Appointment of Statutory Auditor of the Company.

  • Sanofi Consumer - Change in Auditors

    29 Jun 2026, 9:34PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.

  • Sanofi Consumer - Shareholders meeting

    29 Jun 2026, 7:18PM Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 26, 2026. Further,

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:17PM Please find eclosed Voting Results and Consolidated Scrutinizer's Report of the 3rd Annual General Meeting held on 26th June 2026

  • Sanofi Consumer - Shareholders meeting

    26 Jun 2026, 7:21PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 26, 2026

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Outcome of AGM

    26 Jun 2026, 7:18PM Please find enclosed summary of proceeding of the 3rd Annual General Meeting of the Company held today.

  • Sanofi Consumer - Trading Window

    26 Jun 2026, 12:26PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi

  • Sanofi Consumer - Copy of Newspaper Publication

    5 Jun 2026, 12:56PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of 3rd Annual General Meeting of the Company

  • Sanofi Consumer - Shareholder Meeting - AGM On 26Th June 2026

    4 Jun 2026, 11:15PM Business Responsibility and Sustainability Report for FY 2025 is enclosed.

  • Sanofi Consumer - Shareholder Meeting - AGM On 26Th June 2026

    4 Jun 2026, 11:11PM Notice of 3rd AGM of the Company is enclosed

  • Sanofi Consumer - Reg. 34 (1) Annual Report.

    4 Jun 2026, 11:08PM Please find enclosed Annual Report for Financial Year 2025.

  • Sanofi Consumer - Shareholders meeting

    4 Jun 2026, 11:01PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 26, 2026

  • Sanofi Consumer has declared 750% Final dividend for the financial year December 2025

    3 Jun 2026, 2:30PM Sanofi Consumer Healthcare India Ltd. on Wednesday, 25 February 2026, has announced Final dividend of 750 percent on Equity Share, to its shareholders

  • Sanofi Consumer - Copy of Newspaper Publication

    2 Jun 2026, 12:49PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication regarding the convening of the 3rd Annual Gener

  • Sanofi Consumer - Updates

    27 May 2026, 6:44PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Intimation of Book Closure for payment of Final Dividend for FY 2025.

  • Sanofi Consumer - Record Date

    27 May 2026, 6:34PM Sanofi Consumer Healthcare India Limited has informed the Exchange that Record date for the purpose of Dividend is 19-Jun-2026.

  • Sanofi Consumer - General Updates

    27 May 2026, 6:31PM Sanofi Consumer Healthcare India Limited has informed the Exchange about convening of the Third Annual General Meeting of the Company

  • Sanofi Consumer - Intimation Of Record Date For Payment Of Final Dividend For FY 2025

    27 May 2026, 6:16PM The record date for payment of final dividend for FY 2025 is Friday, 19th June 2026

  • Sanofi Consumer - Intimation Of Book Closure For Payment Of Final Dividend For Fy 2025

    27 May 2026, 6:10PM The Register of Member and Share Transfer Book of the Company will remain closed from Saturday, 20th June 2026 to Friday, 26th June 2026.

  • Sanofi Consumer - Intimation Of 3Rd Annual General Meeting Of The Company

    27 May 2026, 6:05PM This is to inform you that the 3rd Annual General Meeting of the Company will be held on Friday, 26th June 2026 through VC/OAVM facility.

  • Sanofi Consumer - Change in Auditors

    25 May 2026, 6:06PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.

  • Sanofi Consumer - Outcome of Board Meeting

    25 May 2026, 6:03PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.

  • Sanofi Consumer - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    25 May 2026, 6:00PM Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold offic

  • Sanofi Consumer - Board Meeting Outcome for Intimation Of Appointment Of Statutory Auditor Pursuant To Regulation 30 Of SEBI

    25 May 2026, 5:55PM Appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as the Statutory Auditors of the Company to fill the casual vacancy and hold offic

  • Sanofi Consumer - Change in Auditors

    30 Apr 2026, 5:54PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.

  • Sanofi Consumer - Copy of Newspaper Publication

    30 Apr 2026, 12:41PM Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication

  • Sanofi Consumer - Press Release

    30 Apr 2026, 12:36PM Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated April 28, 2026, titled ""Sanofi Consumer Healthcare

  • Sanofi Consumer - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors

    30 Apr 2026, 5:53PM This is to inform you that M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants have tendered their resignation as Statutory Auditor of the Company w

  • Sanofi Consumer - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Apr 2026, 12:31PM The Board of Directors at its meeting held on Tuesday, 28th April 2026, considered and approved the Unaudited Financial Results for the quarter ended

  • Sanofi Consumer - Outcome of Board Meeting

    28 Apr 2026, 4:29PM Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter ended March 31, 2026.

  • Sanofi Consumer Q1 net profit up 35.60% at Rs 67.80 cr

    28 Apr 2026, 4:50PM The company reported standalone net profit of Rs 67.80 crore for the quarter ended March 31, 2026 as compared to Rs 50.00 crore in the same period las

  • Sanofi Consumer - Results - Financial Results For March 31, 2026

    28 Apr 2026, 4:38PM Unaudited Financial Results for the quarter ended March 31, 2026 is enclosed.

  • Sanofi Consumer - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, 28Th April 2026

    28 Apr 2026, 4:22PM We wish to inform you that the Board of Directors at its meeting held today i.e., Tuesday 28th April 2026, inter alia considered and approved the Unau

  • Sanofi Consumer - Shareholders meeting

    23 Apr 2026, 7:16PM Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Scrutinizers Report dated 23rd April 2026. Further, the company has informe

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    23 Apr 2026, 7:13PM Please find enclosed Report of Scrutinizer dated 23rd April 2026 issued by M/s. MMJB & Associates LLP

  • Sanofi Consumer - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    23 Apr 2026, 7:08PM Please find enclosed Voting Results for Postal Ballot Notice dated 25th February 2026

  • Sanofi Consumer - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ende

    23 Apr 2026, 5:24PM Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2026 ,inter alia,
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Sanofi Consumer Healthcare India Ltd stock 

Name December-25 December-24 March-24 December-23
Assets 384 1.7 1.7 1.7
Liabilities 384 1.7 1.7 1.7
Equity 23 2 2 2
Gross Profit 309 0 0 -0.3
Net Profit 240.1 0 0 -0.3
Cash From Operating Activities 174.8 -0.4 -0.4 -0.4
NPM(%) 27.33 0 0 29.69
Revenue 878.4 0 0 0
Expenses 569.4 0 0 0.3
ROE(%) 62.52 0 0 -0.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
19 Jun 2026 75 750 0 4009.2
17 Apr 2025 55 550 0 4756.85

Peers

Other companies within the same industry or sector that are comparable to Sanofi Consumer Healthcare India Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1835.00 -1.16 17.13 4186.69 1071.07 0.38
Sharda Cropchem Ltd 873.15 -0.66 11.57 41603.38 754.66 1.72
Amines and Plasticizers Ltd 194.22 0.47 29.25 25371.37 331.99 0.26
Indogulf Cropsciences Ltd 69.55 -0.11 10.99 22497.15 63.31 0.00

Company Info

The Company was incorporated as a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 10, 2023, issued by the Registrar of Companies, Central Registration Centre. Major Events and Milestones:2023 Incorporation of the Company 2024 Demerger, transfer and vesting of the Demerged Undertaking from Sanofi India Limited into the  Company on a going concern basis pursuant to the Scheme  2020 -Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030. 2021 -Sanofi completed acquisition of Kadmon. -Sanofi completed acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics. -Sanofi launched its new global employee share ownership plan. -Sanofi established three-year collaboration with Stanford Medicine to accelerate immunology research. 2022 -Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology. -Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine. -Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth. -Sanofi recognized by S&P as one of the most sustainability- committed companies. -Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board. 2023 -Sanofi's Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability. -Sanofi completes acquisition of Qunol. -Sanofi completes acquisition of Provention Bio, Inc. - Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care. 2024 -Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline. 2025-Sanofi's breakthrough therapy Rezurockr approved in India for treating patients living with chronic graft-versus-host disease.

The Company was incorporated as a public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation dated May 10, 2023, issued by the Registrar of Companies, Central Registration Centre. Major Events and Milestones:2023 Incorporation of the Company 2024 Demerger, transfer and vesting of the Demerged Undertaking from Sanofi India Limited into the  Company on a going concern basis pursuant to the Scheme  2020 -Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030. 2021 -Sanofi completed acquisition of Kadmon. -Sanofi completed acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics. -Sanofi launched its new global employee share ownership plan. -Sanofi established three-year collaboration with Stanford Medicine to accelerate immunology research. 2022 -Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology. -Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine. -Sanofi launches its first Digital Accelerator fueled by new talent and focused on growth. -Sanofi recognized by S&P as one of the most sustainability- committed companies. -Sanofi launches first-in-pharma Diversity, Equity & Inclusion Board. 2023 -Sanofi's Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability. -Sanofi completes acquisition of Qunol. -Sanofi completes acquisition of Provention Bio, Inc. - Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care. 2024 -Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline. 2025-Sanofi's breakthrough therapy Rezurockr approved in India for treating patients living with chronic graft-versus-host disease.

Parent Organisation

Sanofi Consumer Healthcare India Ltd.

Founded

10/05/2023

Managing Director

Mr.Himanshu Bakshi

NSE Symbol

SANOFICONREQ

FAQ